These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3412108)

  • 21. MS-551 and KCB-328, two class III drugs aggravated adrenaline-induced arrhythmias.
    Xue Y; Yamada C; Aye NN; Hashimoto K
    Br J Pharmacol; 1998 Aug; 124(8):1712-8. PubMed ID: 9756388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of kappa-opioid receptors in the regulation of cardiac resistance to arrhythmogenic effects of ischemia and reperfusion].
    Lishmanov AIu; Lasukova TV; Maslov LN; Platonov AA
    Ross Fiziol Zh Im I M Sechenova; 2006 Dec; 92(12):1419-28. PubMed ID: 17523463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevention of adrenaline-induced arrhythmia by a calmodulin blocker, trifluoroperazine].
    Meerson FZ; Malyshev IIu; Larionov NP; Karpov RS
    Biull Eksp Biol Med; 1989 Jul; 108(7):59-62. PubMed ID: 2804303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative effectiveness of the beta-(N,N-diethylamino)ethylamide hydrochloride of fusaric acid, obzidan and atenolol in experimental adrenaline-induced cardiac arrhythmia].
    Savina MD
    Farmakol Toksikol; 1986; 49(3):47-50. PubMed ID: 3720934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antiarrhythmic properties of a cannabinoid (CB) receptor agonist].
    Maslov LN; Lishmanov IuB; Maĭsmekulova LA; Mechoulam P
    Eksp Klin Farmakol; 2001; 64(3):37-40. PubMed ID: 11558437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiarrhythmic evaluation of naloxone against acute coronary occlusion-induced arrhythmias in pigs.
    Bergey JL; Beil ME
    Eur J Pharmacol; 1983 Jun; 90(4):427-31. PubMed ID: 6884431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiarrhythmic effects of bisaramil in canine models of ventricular arrhythmia.
    Haruno A; Hashimoto K
    Eur J Pharmacol; 1993 Mar; 233(1):1-6. PubMed ID: 8472737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Consequences of opiate agonist and antagonist in myocardial ischaemia suggest a role of endogenous opioid peptides in ischaemic heart disease.
    Lee AY; Chen YT; Kan MN; P'eng FK; Chai CY; Kuo JS
    Cardiovasc Res; 1992 Apr; 26(4):392-5. PubMed ID: 1638574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The anti-arrhythmia action of low-molecular polyvinylpyrrolidone in experimental arrhythmias].
    Mirzaev NA
    Eksp Klin Farmakol; 1993; 56(2):24-6. PubMed ID: 8348030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The anti-arrhythmic effect of the mu-opiate receptor agonists in adrenal arrhythmia: the role of the autonomic nervous system].
    Maslov LN; Krylatov AV; Lishmanov IuB
    Biull Eksp Biol Med; 1996 Jul; 122(7):25-7. PubMed ID: 9303692
    [No Abstract]   [Full Text] [Related]  

  • 31. Electrophysiological and antiarrhythmic actions of the kappa agonist PD 129290, and its R,R (+)-enantiomer, PD 129289.
    Pugsley MK; Saint DA; Penz MP; Walker MJ
    Br J Pharmacol; 1993 Dec; 110(4):1579-85. PubMed ID: 8306104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiarrhythmic effects of U-50,488H in rats subject to coronary artery occlusion.
    Pugsley MK; Penz WP; Walker MJ; Wong TM
    Eur J Pharmacol; 1992 Feb; 212(1):15-9. PubMed ID: 1555635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naloxone treatment of endotoxin shock: stereospecificity of physiologic and pharmacologic effects in the rat.
    Faden AI; Holaday JW
    J Pharmacol Exp Ther; 1980 Mar; 212(3):441-7. PubMed ID: 7359345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiarrhythmic profile and endothelial action of novel decahydroquinoline derivatives.
    Kozlovski VI; Vdovichenko VP; Chlopicki S; Malchik SS; Praliyev KD; Zcilkibayev OT
    Pol J Pharmacol; 2004; 56(6):767-74. PubMed ID: 15662089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative study of the antiarrhythmic activity of L-, D-and DL-stereoisomers of potassium magnesium aspartate].
    Spasov AA; Iezhitsa IN; Zhuravleva NV; Gurova NA; Sinolitskiĭ MK; Voronin SP
    Eksp Klin Farmakol; 2007; 70(1):17-21. PubMed ID: 17402586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A proposed mechanism for cardiac sensitisation: electrophysiological study of effects of difluorodichloromethane and adrenaline on different types of cardiac preparations isolated from sheep hearts.
    Lessard Y; Paulet G
    Cardiovasc Res; 1986 Nov; 20(11):807-15. PubMed ID: 3621282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiarrhythmic action of rilmenidine on adrenaline-induced arrhythmia via central imidazoline receptors in halothane-anaesthetized dogs.
    Mammoto T; Kamibayashi T; Hayashi Y; Yamatodani A; Takada K; Yoshiya I
    Br J Pharmacol; 1996 Apr; 117(8):1744-8. PubMed ID: 8732285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Delta-opiate receptors and heart resistance to arrhythmogenic factors].
    Maslov LN; Ugdyzhekova DS; Krylatov AV; Lishmanov IuB
    Ross Fiziol Zh Im I M Sechenova; 1998 Dec; 84(12):1394-401. PubMed ID: 10204186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of the opiate antagonist naloxone on digitalis induced cardiac arrhythmias.
    Rabkin SW; Roob O
    Eur J Pharmacol; 1986 Oct; 130(1-2):47-55. PubMed ID: 3780859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of drugs interacting with opioid receptors on the early ventricular arrhythmias arising from myocardial ischaemia.
    Sitsapesan R; Parratt JR
    Br J Pharmacol; 1989 Jul; 97(3):795-800. PubMed ID: 2547486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.